I agree that this site is using cookies. You can find further informations here.
X
Ajbani, Kanchan
40  results:
Search for persons X
?
1

Updating the approaches to define susceptibility and resist..:

Antimycobacterial Susceptibility Testing Group ; Georghiou, Sophia B. ; Rodwell, Timothy C....
European Respiratory Journal.  59 (2022)  4 - p. 2200166 , 2022
Link: https://doi.org/10.1183/..
 
?
2

Evaluation of CSF pyrosequencing to diagnose tuberculous me..:

Ajbani, Kanchan ; Kazi, Mubin ; Agrawal, Umang...
Tuberculosis.  126 (2021)  - p. 102048 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Targeted next generation sequencing directly from sputum fo..:

Kambli, Priti ; Ajbani, Kanchan ; Kazi, Mubin...
Tuberculosis.  127 (2021)  - p. 102051 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Diagnosis and Management of Osteoarticular Tuberculosis: A ..:

Agashe, Vikas M. ; Rodrigues, Camilla ; Soman, Rajiv...
Indian Journal of Orthopaedics.  54 (2020)  S1 - p. 60-70 , 2020
Link: https://doi.org/10.1007/..
 
?
5

Interpreting very low Mycobacterium tuberculosis detected o..:

Rodrigues, Camilla ; Ajbani, Kanchan ; Naik, Swapna..
Lung India.  36 (2019)  6 - p. 555 , 2019
Link: https://doi.org/10.4103/..
 
?
6

Multiplex PCR to detect pAmpC β-lactamases among enterobact..:

Kazi, Mubin ; Ajbani, Kanchan ; Tornheim, Jeffrey A...
Microbiology.  165 (2019)  2 - p. 246-250 , 2019
Link: https://doi.org/10.1099/..
 
?
7

Pyrosequencing to resolve discrepant Xpert MTB/RIF and Myco..:

Rodrigues, Camilla ; Ajbani, Kanchan ; Kazi, Mubin...
Lung India.  35 (2018)  2 - p. 168 , 2018
Link: https://doi.org/10.4103/..
 
?
8

Evaluation of pyrosequencing for extensive drug resistance-..:

Nambiar, Remya ; Shah, Daksha ; Ajbani, Kanchan...
Tuberculosis.  110 (2018)  - p. 86-90 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Utility of pyrosequencing for rapid detection of tubercular..:

Ajbani, Kanchan ; Kazi, Mubin ; Naik, Swapna...
Tuberculosis.  111 (2018)  - p. 54-56 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Corrigendum to "Correlating rrs and eis promoter mutations ..:

Kambli, Priti ; Ajbani, Kanchan ; Nikam, Chaitali...
International Journal of Mycobacteriology.  5 (2016)  3 - p. 370-372 , 2016
Link: https://doi.org/10.1016/..
 
?
11

Clinical outcomes and safety of colistin in treatment of gr..:

Desai, Kinnari ; Kazi, Mubin ; Ajbani, Kanchan...
The Egyptian Journal of Critical Care Medicine.  4 (2016)  2 - p. 67-72 , 2016
Link: https://doi.org/10.1016/..
 
?
12

Correlating rrs and eis promoter mutations in clinical isol..:

Kambli, Priti ; Ajbani, Kanchan ; Nikam, Chaitali...
International Journal of Mycobacteriology.  5 (2016)  1 - p. 1-6 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Defining multidrug-resistant tuberculosis: correlating Geno..:

Kambli, Priti ; Ajbani, Kanchan ; Sadani, Meeta...
Diagnostic Microbiology and Infectious Disease.  82 (2015)  1 - p. 49-53 , 2015
Link: https://doi.org/10.1016/..
 
?
14

Correlating Minimum Inhibitory Concentrations of ofloxacin ..:

Kambli, Priti ; Ajbani, Kanchan ; Sadani, Meeta...
Tuberculosis.  95 (2015)  2 - p. 137-141 , 2015
Link: https://doi.org/10.1016/..
 
?
15

Multidrug-Resistant Tuberculosis With Fluoroquinolone Resis..:

Ajbani, Kanchan ; Nikam, Chaitali ; Shetty, Anjali..
Clinical Infectious Diseases.  59 (2014)  1 - p. 138-139 , 2014
Link: https://www.jstor.org/st..
 
1-15